ELVN
Price
$45.10
Change
-$0.99 (-2.15%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
3.38B
55 days until earnings call
Intraday BUY SELL Signals
SER
Price
$2.18
Change
-$0.01 (-0.46%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
55.63M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELVN vs SER

ELVN vs SER Comparison Chart in %
View a ticker or compare two or three
VS
ELVN vs. SER commentary
Sep 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Buy and SER is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ELVN vs SER: Fundamental Ratings
ELVN
SER
OUTLOOK RATING
1..100
5495
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
4163
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5033

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELVN's Valuation (33) in the null industry is in the same range as SER (53). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.

SER's Profit vs Risk Rating (95) in the null industry is in the same range as ELVN (100). This means that SER’s stock grew similarly to ELVN’s over the last 12 months.

ELVN's SMR Rating (94) in the null industry is in the same range as SER (100). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.

ELVN's Price Growth Rating (41) in the null industry is in the same range as SER (63). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.

ELVN's P/E Growth Rating (100) in the null industry is in the same range as SER (100). This means that ELVN’s stock grew similarly to SER’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELVNSER
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Sep 24, 2026
Stock price -- (ELVN: $46.09 vs. SER: $2.19)
Brand notoriety: ELVN and SER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 146% vs. SER: 17%
Market capitalization -- ELVN: $3.38B vs. SER: $55.63M
ELVN [@Biotechnology] is valued at $3.38B. SER’s [@Biotechnology] market capitalization is $55.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.87B. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 1 FA rating(s) are green while SER’s FA Score has 0 green FA rating(s).

  • ELVN’s FA Score: 1 green, 4 red.
  • SER’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than SER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 4 TA indicator(s) are bullish while SER’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 4 bullish, 5 bearish.
  • SER’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than SER.

Price Growth

ELVN (@Biotechnology) experienced а -6.17% price change this week, while SER (@Biotechnology) price change was +1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.48%. For the same industry, the average monthly price growth was -11.14%, and the average quarterly price growth was +7.50%.

Reported Earning Dates

ELVN is expected to report earnings on Nov 18, 2026.

SER is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-2.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ELVN
Daily Signal:
Gain/Loss:
SER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PTIR22.171.53
+7.41%
GraniteShares 2x Long PLTR Daily ETF (PTIR)
SHPP33.91N/A
N/A
Pacer Industrials and Logistics ETF (SHPP)
SMIG31.45-0.06
-0.21%
Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG)
EGUS59.07-0.69
-1.15%
iShares ESG Aware MSCI USA Growth ETF (EGUS)
IGI15.95-0.31
-1.91%
Western Asset Investment Grade Opportunity Trust Inc

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with MLTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-4.36%
MLTX - ELVN
44%
Loosely correlated
-3.59%
WVE - ELVN
41%
Loosely correlated
-9.20%
CGON - ELVN
36%
Loosely correlated
-5.63%
CLDX - ELVN
36%
Loosely correlated
-7.13%
ABVX - ELVN
35%
Loosely correlated
-4.23%
More